Eating more protein hits two birds with the same stone
What the Research Says About GLP-1s and HS While clinical research is still in early stages, several studies support what many of us in the HS community have seen anecdotally: A 2024 study of patients with HS found that semaglutide reduced the frequency of flares and systemic inflammationflaring decreased from once every 8.5 weeks to once every 12 weeks
Uhles S, Wang H, Bnardeau A, Prummer M, Brecheisen M, Sewing S, Tobalina L, Bosco D, Wollheim CB, Migliorini C
These medications are incredibly popular and are helping to get people to drop body fat and live healthier lives
Why is fragmented care a concern with GLP-1 therapies
No Insurance Required: The entire program runs on a cash-pay basis, keeping the process simple and accessible without dealing with coverage approvals or prior authorizations